| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,845 |
14,486 |
$6.16M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
54,566 |
40,517 |
$3.48M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,358 |
10,982 |
$3.34M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,284 |
4,924 |
$3.25M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,234 |
22,661 |
$2.76M |
| 80053 |
Comprehensive metabolic panel |
15,265 |
12,274 |
$377K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,513 |
13,005 |
$310K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,425 |
764 |
$213K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,300 |
1,848 |
$199K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,551 |
1,390 |
$162K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,701 |
1,168 |
$129K |
| 99215 |
Prolong outpt/office vis |
1,277 |
868 |
$125K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,000 |
2,792 |
$122K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
7,290 |
6,981 |
$122K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,209 |
3,025 |
$115K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
677 |
550 |
$96K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,181 |
2,998 |
$93K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,444 |
1,190 |
$88K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
677 |
532 |
$84K |
| 80061 |
Lipid panel |
2,225 |
2,067 |
$78K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
292 |
132 |
$65K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,064 |
2,945 |
$60K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
663 |
616 |
$60K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
388 |
355 |
$52K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,520 |
2,131 |
$46K |
| 71045 |
Radiologic examination, chest; single view |
673 |
290 |
$40K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
448 |
417 |
$38K |
| 92504 |
|
1,158 |
914 |
$37K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
342 |
289 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
940 |
619 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
835 |
376 |
$32K |
| 90837 |
Psychotherapy, 53 minutes with patient |
533 |
177 |
$29K |
| 81001 |
|
1,520 |
1,287 |
$27K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
414 |
147 |
$26K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,558 |
713 |
$23K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
184 |
177 |
$20K |
| 90834 |
Psychotherapy, 45 minutes with patient |
295 |
131 |
$18K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
170 |
153 |
$17K |
| D0191 |
|
2,867 |
2,790 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
184 |
177 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
245 |
116 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
264 |
207 |
$15K |
| 99188 |
|
1,845 |
1,797 |
$14K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
44 |
43 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
296 |
285 |
$14K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
273 |
233 |
$13K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
135 |
87 |
$13K |
| 84484 |
|
358 |
277 |
$13K |
| 85027 |
|
516 |
490 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
450 |
386 |
$12K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
56 |
25 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
105 |
85 |
$10K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
37 |
27 |
$10K |
| 87641 |
|
157 |
144 |
$10K |
| J3490 |
Unclassified drugs |
448 |
155 |
$9K |
| 82607 |
|
225 |
211 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
214 |
162 |
$8K |
| 88142 |
|
137 |
131 |
$8K |
| 82728 |
|
246 |
216 |
$7K |
| 81003 |
|
403 |
380 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
299 |
281 |
$7K |
| 87081 |
|
225 |
175 |
$7K |
| 83690 |
|
149 |
128 |
$6K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
30 |
24 |
$6K |
| 98926 |
|
121 |
97 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
357 |
317 |
$6K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
164 |
150 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
32 |
12 |
$6K |
| 20610 |
|
74 |
40 |
$6K |
| 83655 |
|
99 |
95 |
$6K |
| 86803 |
|
158 |
144 |
$6K |
| 31231 |
|
50 |
37 |
$6K |
| 87522 |
Neg quan hep c or qual rna |
31 |
27 |
$5K |
| 84466 |
|
218 |
186 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
342 |
294 |
$5K |
| 92567 |
|
270 |
264 |
$5K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
36 |
25 |
$4K |
| 83540 |
|
266 |
229 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
151 |
132 |
$4K |
| 92557 |
|
96 |
94 |
$4K |
| 99205 |
Prolong outpt/office vis |
25 |
19 |
$4K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
24 |
13 |
$3K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
34 |
24 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
181 |
154 |
$3K |
| 90686 |
|
265 |
260 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
43 |
42 |
$3K |
| 84439 |
|
68 |
67 |
$2K |
| 31575 |
|
13 |
12 |
$2K |
| 87210 |
|
89 |
87 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
143 |
123 |
$2K |
| 86705 |
|
50 |
44 |
$1K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
18 |
12 |
$1K |
| 82962 |
|
174 |
147 |
$1K |
| 82977 |
|
168 |
94 |
$1K |
| 99442 |
|
52 |
48 |
$1K |
| 73562 |
|
26 |
12 |
$1K |
| 82948 |
|
138 |
110 |
$1K |
| 87653 |
|
12 |
12 |
$1K |
| 73630 |
|
50 |
14 |
$898.06 |
| 83615 |
|
70 |
37 |
$832.02 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
113 |
104 |
$728.65 |
| 85018 |
|
42 |
41 |
$696.88 |
| 99174 |
|
78 |
75 |
$583.00 |
| 87400 |
|
33 |
13 |
$563.12 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
22 |
13 |
$520.58 |
| 87070 |
|
14 |
14 |
$515.11 |
| 0001A |
|
12 |
12 |
$498.80 |
| 90480 |
|
12 |
12 |
$480.00 |
| 90474 |
|
39 |
38 |
$454.54 |
| 90473 |
|
27 |
26 |
$449.50 |
| 83735 |
|
14 |
14 |
$428.01 |
| Q2036 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
51 |
48 |
$385.84 |
| G0451 |
Development testing, with interpretation and report, per standardized instrument form |
1,658 |
1,556 |
$374.24 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$365.40 |
| 90715 |
|
13 |
13 |
$339.96 |
| 83721 |
|
14 |
13 |
$303.64 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,133 |
1,102 |
$241.44 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16 |
12 |
$186.60 |
| A0425 |
Ground mileage, per statute mile |
80 |
54 |
$183.75 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
21 |
15 |
$175.37 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$75.96 |
| 1160F |
|
8,456 |
7,713 |
$0.00 |
| 1159F |
|
13,496 |
12,212 |
$0.00 |
| 84145 |
|
15 |
15 |
$0.00 |
| 3008F |
|
4,532 |
4,315 |
$0.00 |
| 3079F |
|
12 |
12 |
$0.00 |